Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Head & Neck 1Gynecologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 281Head and Neck Neoplasms 258Nasopharyngeal Carcinoma 127Oropharyngeal Neoplasms 57Carcinoma, Squamous Cell 54Nasopharyngeal Neoplasms 41Laryngeal Neoplasms 35Mouth Neoplasms 30Hypopharyngeal Neoplasms 29Carcinoma 24Salivary Gland Neoplasms 19Carcinoma, Non-Small-Cell Lung 16Tongue Neoplasms 15Neoplasm Metastasis 13Laryngeal Diseases 13Recurrence 12Neoplasms 10Parkinson Disease 4, Autosomal Dominant Lewy Body 8Mucositis 8Stomach Neoplasms 7Pharyngeal Neoplasms 7Papillomavirus Infections 7Ovarian Neoplasms 7Lung Neoplasms 7Radiation Injuries 6Pancreatic Neoplasms 6Neoplasms, Squamous Cell 6Esophageal Neoplasms 6Colorectal Neoplasms 6Thyroid Neoplasms 5

Interventions

Palonosetron 2fosaprepitant 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiotherapy 1Olanzapine 1Electroacupuncture 1Dexamethasone 1Cisplatin 1Calcium Dobesilate 1Aprepitant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nausea × Cisplatin × Head & Neck × Clear all
NCT00895245 2017-05-18

Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy

University of Washington

Phase 2 Terminated
6 enrolled 5 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡